Mangaluru: Yenepoya Specialty Hospital, Kodialbail, has performed two successful bone marrow transplants by a team led by Dr ...

"Cellenkos gains FDA orphan drug status for CK0804 to treat myelofibrosis" was originally created and published by ...

Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that ...

Cellenkos® Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf, regulatory T cell (Treg) ...

An oncology pharmacist shares how a treatment takes a different approach to treating chronic graft-versus-host disease (GVHD) ...

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

CK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options. CK0804, an investigational allogeneic regulatory T cell ...

For patients who may benefit from such scans, it's unclear whether including the spine as well as the sacroiliac joint ...

The film-maker has been hailed as one a difference maker who was one of the brains behind the most impactful documentaries of ...

Pneumonia is an infection that affects one or both lungs. The disease can range from mild to severe and can be fatal. It is typically ...

Some cancers may not require immediate treatment, from prostate cancer to thyroid tumors. Medical experts share when ...

Two Complete Metabolic Responses (CMRs) observed in patients with relapsed/refractory metastatic Ewing sarcoma and one ...